Search
|
Proceedings
|
Concurrent Oral Session Grid
|
Author Index
|
eBook
Author Index: P
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Padula, W. V.
2
* A COST-EFFECTIVENESS ANALYSIS OF OFF-LABEL BIOLOGICS TO TREAT SARCOID POSTERIOR UVEITIS VERSUS STANDARD OF CARE: COMPARING INFLIXIMAB TO METHOTREXATE AND SYSTEMIC STEROIDS
Pagnoux, C.
46
COST OF THERAPIES TO INDUCE REMISSION IN PATIENTS WITH WEGENER'S GRANULOMATOSIS
Paltiel, A. D.
I
INNOVATIVE METHODS LUSTED FINALISTS
Pandya, A.
I-2
* DECISIONS, DECISIONS: CAN DIRECT-SEARCH OPTIMIZATION OF CONTINUOUS DECISION VARIABLES RESULT IN SUBSTANTIAL WELFARE GAINS COMPARED TO USUAL METHODS?
PM10
METHODS OF DISEASE MODEL CALIBRATION: THEORY AND PRACTICE
Pape, J. W.
TR2-3
* INTERNAL VALIDATION AND CALIBRATION OF A MODEL TO FORECAST HIV TREATMENT DEMAND AND CAPACITY IN HAITI
Papier, A.
18
TEACHING MEDICAL STUDENTS DIAGNOSTIC ERROR USING THE PROBLEM BASED LEARNING (PBL) METHOD: A CASE OF CELLULITIS MISDIAGNOSIS
Pardo, S. T.
A-6
* REWARD SENSITIVITY, TEMPORAL DISCOUNTING, GENDER AND RISKY HEALTH BEHAVIORS: A FUZZY-TRACE THEORY APPROACH
Parisi, S. M.
14
CLINICAL DECISION SUPPORT TO PROMOTE SAFE PRESCRIBING TO WOMEN OF REPRODUCTIVE AGE: DIFFERENTIAL EFFECTS BY SUBGROUP
Parsons, S. K.
O-4
POPULATION SCREENING TRADE OFFS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SCREENING ASYMPTOMATIC CHILDREN FOR CARDIAC DISORDERS THAT CAUSE SUDDEN CARDIAC DEATH
Partrick, D.
D-2
WHO IS GUIDING DECISIONS ABOUT WHETHER TO PERFORM PEDIATRIC GASTRIC FUNDOPLICATION?
Partridge, A.
41
THE QUALITY OF DECISIONS ABOUT BREAST CANCER SURGERY
Pauker, S. G.
39
* RISKS AND BENEFITS OF PROSTATE BIOPSY FOLLOWING AN ABNORMAL PSA SCREEN IN GENERAL AND IN A SPECIFIC PATIENT: DECISION ANALYSES
Paulden, M.
31
COST-EFFECTIVENESS OF THE MOST COMMONLY USED NON-SURGICAL TREATMENTS FOR NECK PAIN
B-3
INVESTMENT AND DISINVESTMENT OF HEALTH TECHNOLOGIES: THE NEED FOR
TWO
COST-EFFECTIVENESS THRESHOLDS
N-2
COST-EFFECTIVENESS OF NON-INVASIVE CARDIAC IMAGING TECHNOLOGIES IN OUTPATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE
O-1
YOU CAN'T GET HERE FROM THERE: METHODS FOR COST CONVERSION BETWEEN HEALTH CARE SYSTEMS NEED TO BE REEXAMINED
TR2-4
GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, 21-GENE ASSAY AND CHEMOTHERAPY
Paulman, A.
51
DOES PQRI MAKE A DIFFERENCE?
Pazo, V.
7
FREQUENT FAILURE TO RECOGNIZE WEIGHT LOSS AND DIAGNOSE ITS CAUSE IN THE AMBULATORY SETTING
Pearson, S.
47
ONLINE RESOURCES FOR CANCER CARE: A QUALITY ASSESSMENT OF EVIDENCE-BASED GUIDELINES AND PROTOCOLS
Peipert, J.
3
VALUES AND PREFERENCES IMPORTANT IN CONTRACEPTIVE DECISION MAKING: A QUALITATIVE STUDY
Pennington, M. W.
O-6
EXPLOITING LARGE OBSERVATIONAL DATA SETS FOR COMPARATIVE EFFECTIVENESS RESEARCH: THE EXAMPLE OF HIP REPLACEMENT
Perestelo Perez, L.
5
PSYCHIATRIC PATIENTS' ATTITUDES TOWARDS SHARED DECISION MAKING
12
HEALTH CARE MANAGERS' PERSPECTIVE ON SHARED DECISION MAKING IN SPAIN
Perez-Ramos, J.
5
PSYCHIATRIC PATIENTS' ATTITUDES TOWARDS SHARED DECISION MAKING
12
HEALTH CARE MANAGERS' PERSPECTIVE ON SHARED DECISION MAKING IN SPAIN
Perzynski, A. T.
19
* ACCEPTABILITY OF TEXT MESSAGING AS A TOOL TO COMMUNICATE WITH CHRONIC LIVER DISEASE PATIENTS
31
PROJECTION BIAS AMONG PERSONS RECEIVING SPINAL INJECTION AS TREATMENT FOR LUMBAR PAIN
Petchy, M.
1
AUTOMATING THE QUALITY ASSURANCE REVIEW PROCESS
WHAT DID YOU MEAN BY PE? A CASE OF AN UNSAFE ABBREVIATION
Peters, C. M.
40
DEVELOPMENT AND VALIDATION OF A GLAUCOMA SPECIFIC UTILITY ELICITATION INSTRUMENT
Peters, E.
2
IMPROVING PAIN ASSESSMENT IN CLINICAL PRACTICE
F-5
“NUDGING” PATIENTS TOWARDS ACCEPTING STRONG RECOMMENDATIONS
Peters, E.
WHEN DECISIONS DEPART FROM RATIONALITY: EVIDENCE-BASED STRATEGIES FOR UNDERSTANDING “REAL” PATIENT CHOICES
Peterson, T.
L-4
* MODELING CARE UTILIZATION RATIOS TO GUIDE SURGE RESPONSES FOR NON-CRISIS EVENTS
Petrosyan, V.
40
INFLUENCE OF FINANCING AND PAYMENT MECHANISMS ON MEDICAL DECISION MAKING: NORMAL DELIVERY VS. CESAREAN SECTION
51
PERCEPTIONS AND REALITIES OF FOOD FORTIFICATION IN PREVENTING ANEMIA
Pham, B.
TR2-4
GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, 21-GENE ASSAY AND CHEMOTHERAPY
Philippe, C.
TR1-2
FACTORS INFLUENCING PHYSICIANS' THERAPEUTIC DECISION WHEN PRESCRIBING CHEMOTHERAPY: A DISCRETE CHOICE EXPERIMENT
Philipson, T. J.
THE DISCOVERY, FINANCING AND EVALUATION OF GENOMIC MEDICINE: IMPLICATIONS FOR THE COMPARATIVE EFFECTIVENESS OF CANCER CARE
Pickard, A. S.
G-1
EFFECT OF CHRONIC CONDITIONS ON THE VALUATION OF HYPOTHETICAL EQ-5D HEALTH STATES
Pignone, M.
47
USABILITY AND EFFICACY TESTING OF A SPANISH LANGUAGE COLORECTAL CANCER SCREENING DECISION AID IN LATINOS WITH LIMITED ENGLISH PROFICIENCY
D-1
TOWARD MINIMUM STANDARDS FOR THE CERTIFICATION OF PATIENT DECISION AIDS: A CORRELATION ANALYSIS AND MODIFIED DELPHI CONSENSUS PROCESS
L-2
* ESTIMATING THE COST OF NO-SHOWS AND EVALUATING THE EFFECTS OF MITIGATION STRATEGIES
M
DECISION AIDS AND DECISION SUPPORT
Pillai, D.
10
IS A BIRD IN THE HAND WORTH MORE THAN THREE IN THE BUSH? THE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF CONJUGATE PNEUMOCOCCAL VACCINE PROGRAM OPTIONS IN ONTARIO, CANADA
Pilliod, R. A.
9
* UNIVERSAL NEWBORN SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY: A COST EFFECTIVENESS ANALYSIS
Pinto, D.
13
* COST-EFFECTIVENESS OF MANUAL THERAPY, EXERCISE, AND MANUAL THERAPY AND EXERCISE COMBINED FOR THE MANAGEMENT OF OSTEOARTHRITIS OF THE HIP AND/OR KNEE
Pinto-Foltz, M. D.
M-1
SHARED DECISION MAKING? EXAMINING MOTHER AND DAUGHTER INFLUENCE ON THE CHOICE TO VACCINATE AGAINST THE HUMAN PAPILLOMAVIRUS
Pirollo, M.
15
DOES IMPROVED NUMERACY MAKE THE GLASS HALF FULL? CANCER PATIENTS' OPTIMISM, NUMERACY, AND PERCEPTIONS OF THE COSTS OF TREATMENT
Pitrelli, K.
43
ADOPTION DECISIONS FOR NEW RADIOTHERAPY TECHNOLOGY FOR BREAST CANCER
Pitsch, R. K.
M-4
INFORMED DECISION MAKING ABOUT BREAST CANCER CHEMOPREVENTION: RCT OF AN ONLINE DECISION AID INTERVENTION
Pleil, A.
40
DEVELOPMENT AND VALIDATION OF A GLAUCOMA SPECIFIC UTILITY ELICITATION INSTRUMENT
Plich, A.
N-1
DRONEDARONE COST OFFSET ACHIEVED BY REDUCTION OF ATRIAL FIBRILLATION/FLUTTER PATIENT HOSPITALIZATION: RESULTS FROM THE FIRST 12 MONTHS OF FOLLOW-UP DURING THE ATHENA TRIAL
Pliskin, J. S.
AM3
FOCUSED OPERATIONS MANAGEMENT IN HEALTH CARE ORGANIZATIONS: DOING MORE WITH EXISTING RESOURCES
Pogach, L.
TR2-5
ESTIMATING UTILITIES FOR CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES USING TRANSFORMED SF-36 AND SF-12 RESPONSES: CHALLENGES IN A VETERAN POPULATION
Politi, M.
12
TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING: AN INTERNATIONAL ENVIRONMENTAL SCAN
D-1
TOWARD MINIMUM STANDARDS FOR THE CERTIFICATION OF PATIENT DECISION AIDS: A CORRELATION ANALYSIS AND MODIFIED DELPHI CONSENSUS PROCESS
Pollack, L. M.
29
OBESITY AND MORTALITY IN PERSONS WITH AND WITHOUT OBESITY-RELATED DISEASES: USING DATA FROM NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY III
Polsky, D.
TR1
CONCURRENT PRESENTATION OF TOP-RANKED ABSTRACTS - 1 - DECISION PSYCHOLOGY AND QUANTITATIVE METHODS
Popper, N.
16
* ANALYZING CLAIMS DATA FOR HEALTH SERVICES USE IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
48
EVALUATION OF CANCER INCIDENCE IN AUSTRIA AND TREATMENT PATHWAY IDENTIFICATION IN INTRAMURAL AND EXTRAMURAL HEALTH CARE BASED ON LONGITUDINAL ACCOUNTING DATA
E-6
* SOCIAL INTERACTION MODULES IN EPIDEMIC MODELS FOR THE SIMULATION OF INFECTIOUS DISEASES AND EVALUATION OF INTERVENTIONS
Posencheg, M.
47
THE DEVELOPMENT OF A DECISION-AID TO GUIDE COUNSELING OF PARENTS FACING IMMINENT EXTREME PREMATURE DELIVERY
Poses, R. M.
PM13
WHY DO PHYSICIANS NOT PRACTICE ACCORDING TO THE EVIDENCE?
Powell, J.
8
HEALTH CARE COMMISSIONING IN THE ENGLISH NHS: EVIDENCE, CO-PRODUCTION AND QUALITY OF DECISIONS
23
RATIONAL DECISION MAKING REVISITED: INSIGHTS FROM STUDYING INDIVIDUAL HEALTHCARE FUNDING DECISIONS IN ENGLAND
Priest, J. L.
49
IMPACT OF NONCOMPLIANCE WITH DIABETES CARE GUIDELINES ON EMERGENCY ROOM VISITS AND HOSPITALIZATIONS IN A CALIFORNIA MEDICAID TYPE 2 DIABETES MELLITUS POPULATION
Pronovost, P. J.
20-YEAR SUMMARY OF US MALPRACTICE CLAIMS FOR DIAGNOSTIC ERRORS FROM 1985-2005
Prosser, L.
3
* ESTIMATING MEDICAL EXPENDITURES FOR CHILDHOOD OBESITY COST-EFFECTIVENESS ANALYSES
6
* ULNAR NEUROPATHY AT THE ELBOW: A COST-UTILITY ANALYSIS
G-4
SPILLOVER DISUTILITY OF CHRONIC CONDITIONS IN US: MENTAL DISORDERS HAVE GREATEST EFFECT ON FAMILY MEMBERS
Puyana, J. C.
H-2
* COST-EFFECTIVENESS OF USING TRANEXAMIC ACID INFUSION IN TRAUMA PATIENTS WITH SIGNIFICANT HEMORRHAGE
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
